Atrial fibrillation: current therapeutic options].

Abstract Text

The treatment of atrial fibrillation still remains challenging in everyday practice. Even after the introduction of catheter ablation, the decision making about the type of therapy became more complex. The recently published guidelines of the American Heart Association, the American College of Cardiology, and the European Society of Cardiology clearly show therapeutic approaches for different types of atrial fibrillation. The fear of thromboembolism still forces the physician to restore sinus rhythms and perform a perfect anticoagulation. Based on large studies, we are able to decide for each patient individually whether oral anticoagulation or acetylsalicylic acid/clopidogrel are required. Future studies in a large cohort of patients are still necessary to clarify the value of interventional therapy in conjunction with antiarrhythmic drug therapy. These will provide patients with a safe therapy and high quality of life despite presenting paroxysmal or persistent atrial fibrillation.

Authors :-,


Mesh Headings :-


Chemical List :-, ,



2016-09-04 01:37:43

Click download button below to get the free Atrial fibrillation: current therapeutic options]. link to pdf of abstract on your facebook profile.

Download Server - Asia Download Server - America Download Server - Europe Download Server - Australia
Citation:- Lüderitz B, .Atrial fibrillation: current therapeutic options]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()147-9 DOI:



Details of Journal

Journal Title - Medizinische Klinik (Munich, Germany : 1983)

ISSN - 0723-5003

Volume - 101

Issue - 0

Publish date - 2006-Mar

Language - ger

Country - Germany


SHARE PLEASE -
Read More Similar Articles

Possibilities of reducing heart rate by I(f)-channel inhibitors].

Hennersdorf MG, .Possibilities of reducing heart rate by I(f)-channel inhibitors]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()150-2 DOI:.......

Read More

Stierle HE, .New strategies in diagnosis and therapy of vasculitides]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()143-6 DOI:.......


Functional and inflammatory bowel disorders].

Frieling T, .Functional and inflammatory bowel disorders]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()139-42 DOI:.......

Read More

HFE mutations in idiopathic dilated cardiomyopathy.

Erhardt A, Mellenthin A, Perings A, Hennersdorf A, Reinecke A, Strauer A, .HFE mutations in idiopathic dilated cardiomyopathy. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()135-8 DOI:.......

Read More

Update hepatitis D].

Erhardt A, Starke A, Loerke A, Giesecke A, Heintges A, Häussinger A, .Update hepatitis D]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()127-34 DOI:.......

Read More

Myelodysplastic syndromes--new treatment options].

Germing U, .Myelodysplastic syndromes--new treatment options]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()123-6 DOI:.......

Read More

Therapy of acute decompensated heart failure with levosimendan].

Müller K, Peters K, Zeus K, Hennersdorf K, Strauer K, .Therapy of acute decompensated heart failure with levosimendan]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()119-22 DOI:.......

Read More

Quality assurance and guidelines in intensive care medicine].

Graf J, .Quality assurance and guidelines in intensive care medicine]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()115-8 DOI:.......

Read More

Specific therapy in acute liver failure].

Canbay A, Gerken A, .Specific therapy in acute liver failure]. Medizinische Klinik (Munich, Germany : 1983) 2006-Mar;101()111-4 DOI:.......

Read More